The popularity of Viagra initially sparked a surge for pharma, but recent shifts present a murky scenario for those considering a stake. Lower-cost alternatives are reducing revenue, and continued patent challenges add https://laylamyzm506538.liberty-blog.com/41467237/viagra-and-pharma-a-volatile-investment